Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus
- PMID: 20659327
- PMCID: PMC2945049
- DOI: 10.1186/ar3101
Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus
Abstract
Introduction: Systemic lupus erythematosus (SLE) is a highly heterogeneous disorder, characterized by differences in autoantibody profile, serum cytokines, and clinical manifestations. SLE-associated autoantibodies and high serum interferon alpha (IFN-α) are important heritable phenotypes in SLE which are correlated with each other, and play a role in disease pathogenesis. These two heritable risk factors are shared between ancestral backgrounds. The aim of the study was to detect genetic factors associated with autoantibody profiles and serum IFN-α in SLE.
Methods: We undertook a case-case genome-wide association study of SLE patients stratified by ancestry and extremes of phenotype in serology and serum IFN-α. Single nucleotide polymorphisms (SNPs) in seven loci were selected for follow-up in a large independent cohort of 538 SLE patients and 522 controls using a multi-step screening approach based on novel metrics and expert database review. The seven loci were: leucine-rich repeat containing 20 (LRRC20); protein phosphatase 1 H (PPM1H); lysophosphatidic acid receptor 1 (LPAR1); ankyrin repeat and sterile alpha motif domain 1A (ANKS1A); protein tyrosine phosphatase, receptor type M (PTPRM); ephrin A5 (EFNA5); and V-set and immunoglobulin domain containing 2 (VSIG2).
Results: SNPs in the LRRC20, PPM1H, LPAR1, ANKS1A, and VSIG2 loci each demonstrated strong association with a particular serologic profile (all odds ratios > 2.2 and P < 3.5 × 10-4). Each of these serologic profiles was associated with increased serum IFN-α. SNPs in both PTPRM and LRRC20 were associated with increased serum IFN-α independent of serologic profile (P = 2.2 × 10-6 and P = 2.6 × 10-3 respectively). None of the SNPs were strongly associated with SLE in case-control analysis, suggesting that the major impact of these variants will be upon subphenotypes in SLE.
Conclusions: This study demonstrates the power of using serologic and cytokine subphenotypes to elucidate genetic factors involved in complex autoimmune disease. The distinct associations observed emphasize the heterogeneity of molecular pathogenesis in SLE, and the need for stratification by subphenotypes in genetic studies. We hypothesize that these genetic variants play a role in disease manifestations and severity in SLE.
Figures



Similar articles
-
Novel genetic associations with interferon in systemic lupus erythematosus identified by replication and fine-mapping of trait-stratified genome-wide screen.Cytokine. 2020 Aug;132:154631. doi: 10.1016/j.cyto.2018.12.014. Epub 2019 Jan 24. Cytokine. 2020. PMID: 30685201 Free PMC article.
-
Gene-expression-guided selection of candidate loci and molecular phenotype analyses enhance genetic discovery in systemic lupus erythematosus.Clin Dev Immunol. 2012;2012:682018. doi: 10.1155/2012/682018. Epub 2012 Jul 25. Clin Dev Immunol. 2012. PMID: 22988468 Free PMC article.
-
Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.Genes Immun. 2015 Jan-Feb;16(1):15-23. doi: 10.1038/gene.2014.57. Epub 2014 Oct 23. Genes Immun. 2015. PMID: 25338677 Free PMC article.
-
The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry.Gene. 2018 Aug 20;668:59-72. doi: 10.1016/j.gene.2018.05.041. Epub 2018 May 25. Gene. 2018. PMID: 29775752 Review.
-
Interferon regulatory factors in human lupus pathogenesis.Transl Res. 2011 Jun;157(6):326-31. doi: 10.1016/j.trsl.2011.01.006. Epub 2011 Feb 8. Transl Res. 2011. PMID: 21575916 Free PMC article. Review.
Cited by
-
Genetics of SLE: functional relevance for monocytes/macrophages in disease.Clin Dev Immunol. 2012;2012:582352. doi: 10.1155/2012/582352. Epub 2012 Oct 16. Clin Dev Immunol. 2012. PMID: 23227085 Free PMC article. Review.
-
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.Arthritis Rheumatol. 2014 Feb;66(2):390-6. doi: 10.1002/art.38220. Arthritis Rheumatol. 2014. PMID: 24504811 Free PMC article.
-
Interferon regulatory factors: critical mediators of human lupus.Transl Res. 2015 Feb;165(2):283-95. doi: 10.1016/j.trsl.2014.10.002. Epub 2014 Oct 13. Transl Res. 2015. PMID: 25445206 Free PMC article. Review.
-
Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.Adv Exp Med Biol. 2017;1036:19-31. doi: 10.1007/978-3-319-67577-0_2. Adv Exp Med Biol. 2017. PMID: 29275462 Free PMC article. Review.
-
Nucleic Acid sensors and type I interferon production in systemic lupus erythematosus.Front Immunol. 2013 Oct 7;4:319. doi: 10.3389/fimmu.2013.00319. Front Immunol. 2013. PMID: 24109483 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases